September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Katsuaki Maehara: TTF-1 is a New Marker to Identify Patients Best Suited for Lung Cancer KRAS Inhibitors 
Jul 2, 2025, 16:42

Katsuaki Maehara: TTF-1 is a New Marker to Identify Patients Best Suited for Lung Cancer KRAS Inhibitors 

Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X about a recent paper shared by Ferdinandos Skoulidis et al. published in Nature:

“TTF-1 is a new marker to identify patients best suited for lung cancer KRAS inhibitors

Sotorasib – KRAS G12C mut

Lung cancer patients with high TTF-1 expression had improved survival outcomes after treatment with the KRAS inhibitor Sotrasib.

This biomarker may help identify patients who will benefit most from Sotrasib and those who need alternative or combination therapies.

TTF-1 is an easily accessible biomarker commonly used to diagnose lung cancer.”

Title: Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancer

Authors: Ferdinandos Skoulidis, Bob T. Li, Adrianus Johannes de Langen, David S. Hong, Herve Lena, Juergen Wolf, Grace K. Dy, Alessandra Curioni Fontecedro, Pascale Tomasini, Vamsidhar Velcheti, Anthonie J. van der Wekken, Christophe Dooms, Luis Paz-Ares Rodriguez, Giannis Mountzios, Adrian Sacher, Ernest Nadal, Sebastien Couraud, Sang-We Kim, Kenneth O’Byrne, Danilo Rocco, Ryo Toyozawa, Izabela Chmielewska, Colin R. Lindsay, Antreas Hindoyan, Lata Mukundan, Tomasz Wilmanski, Abraham Anderson, Christine Ardito-Abraham, Amrita Pati, Anita Reddy, Bhakti Mehta and Martin Schuler

Read Full Article.

Katsuaki Maehara

More posts featuring Katsuaki Maehara.